Influence of immunohematological markers on severity of in vivo hemolysis in human warm autoimmune haemolytic anemia


      Autoantibody production in autoimmune haemolytic anemia (AIHA) is the result of the loss of self-immunological tolerance of the host. Here we investigated the various immunohematological markers that may influence the severity of in vivo hemolysis in warm AIHA (WAIHA). Complete direct antiglobulin test (DAT) evaluation and immunohematological characterization were performed in 247 patients of WAIHA following departmental protocols. Clinical and laboratory details of patients were obtained from patient file. The median age of WAIHA patients was 47 years with a female preponderance. Lymphoproliferative diseases were the major underlying causes of secondary WAIHA. The mean haemoglobin (Hb) and reticulocyte count (Retic) were 6.43 gm/dL and 7.58% respectively. Single autoantibody bound to red cells was investigated in 151 patients. The main IgG subclass was IgG1. Multiple autoantibodies like IgG+ C, IgG+IgA and IgG+IgA+C were found in 87 (35.2%) patients. Free autoantibodies were observed in 112 patients with a median indirect antiglobulin test (IAT) reactivity of 2+. Derangement of haematological and biochemical values was statistically significant with increase in DAT reactivity, presence of multiple autoantibodies on red cells, coating of red cells by IgG3 or multiple IgG subclass, higher DAT dilution and increasing IAT reactivity. We conclude that several important but simple immunohematological parameters may influence the degree of in vivo hemolysis in WAIHA. Since a set of common haematological and biochemical test determines the severity of in vivo hemolysis therefore a comprehensive clinical and immunohematological evaluation is advisable for a correct diagnostic and therapeutic workup of WAIHA.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cotran R.S.
        • Kumar V.
        • Collins T.
        Disease of Immunity. Robins Pathological Basis of Disease. 6th ed.,. W.B Saunders Company,, USA1999: 212-214
        • Ring G.H.
        • Lakkis F.G.
        Breakdown of self tolerance and the pathogenesis of autoimmunity.
        Semin Nephrol. 1999; 19: 25-33
        • Theofilopoulus A.N.
        • dixon F.J.
        Murine models of systemic lupus erythematosus.
        Adv Immunol. 1985; 37: 269
        • Gehrs B.C.
        • Friedberg R.C.
        Autoimmune hemolytic anemia.
        Am J Hematol. 2002; 69: 258-271
        • Garratty G.
        Autoimmune hemolytic anemia.
        in: Garratty G. Immunobiology of Transfusion Medicine. Marcel Dekker, New York, USA1994: 493-522
        • Abramson N.
        • Gelfand E.W.
        • Jandl J.H.
        • et al.
        The interaction between human monocytes and red cells: specificity for IgG subclasses and IgG fragments.
        J Exp Med. 1970; 132: 1207-1215
        • Chaplin H.J.R.
        Red cell bound immunoglobulin as a predictor of severity of hemolysis in patients with autoimmune hemolytic anemia.
        Transfusion. 1990; 30: 576-578
        • Garratty G.
        • Nance S.J.
        Correlation between in vivo hemolysis and the amount of red cell-bound IgG measured by flow cytometry.
        Transfusion. 1990; 30: 617-621
        • Sokol R.J.
        • Hewitts S.
        • Stamps B.K.
        Autoimmune hemolysis: an 18 years study of 865 cases referred to a regional transfusion center.
        Br Med J. 1981; 282: 2023-2027
        • Petz L.D.
        • Garratty G.
        Immune Hemolytic Anemias. 2nd edition.,. Churchill Livingstone,, Philadelphia, Pa, USA2004
        • Barcellini W.
        • Fattizzo B.
        Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia.
        Dis Markers. 2015; 2015635670
        • Barcellini W.
        • Fattizzo B.
        • Zaninoni A.
        • et al.
        Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.
        Blood. 2014; 124: 2930-2936
        • Shih A.W.Y.
        • Mcfarlane A.
        • Verhovsek M.
        Haptoglobin testing in hemolysis: measurement and interpretation.
        Am J Hematol. 2014; 89: 443-447
      1. Product inserts; Cat-004041, Cat-004851, Cat-004043V, Cat-004033V, BIO-RAD /DiaMed GmbH, 1785 Cressier s/Morat, Switzerland.

        • Fung M.K.
        Investigation of a positive DAT result.
        Technical Manual. 18th ed..,. American Association of Blood Banks,, Bethesda, Maryland2018
        • Leger R.M.
        The positive direct antiglobulin test and immune mediated hemolysis.
        Technical Manual. 18th ed..,. American Association of Blood Banks,, Bethesda, Maryland2018: 425-448
        • Das S.S.
        • Zaman R.U.
        • Safi M.
        Incompatible blood transfusion: Challenging yet lifesaving in the management of acute severe autoimmune hemolytic anemia.
        Asian J Transfus Sci. 2014; 8: 105-108
        • Wheeler C.A.
        • Calhoun L.
        • Blackall D.P.
        Warm reactive autoantibodies: Clinical and serological correlations.
        Am J Clin Pathol. 2004; 122: 680-685
        • Goronzy J.J.
        • Li G.
        • Yang Z.
        • et al.
        The janus head of T cell aging - autoimmunity and immunodeficiency.
        Front Immunol. 2013; 4: 131
        • Packman C.H.
        Hemolytic anemia due to warm autoantibodies.
        Blood Rev. 2008; 22: 17-31
        • Duffy T.P.
        Autoimmune hemolytic anemia and paroxysmal nocturnal hemoglobinuria.
        in: Simon T.L. Dzik W.H. Synder E.L. Stowell Cpand Strauss R.G. Rossi’s Principles of Transfusion Medicine. 3rd ed.,. Lippincott Williams and Wilkins publication, Philadelphia, USA2002
        • Pirofsky B.
        Clinical aspects of autoimmune hemolytic anemia.
        Semin Hematol. 1976; 13: 251-265
        • Das S.S.
        • Nityanand S.
        • Chaudhary R.
        Clinical and serological characterization of autoimmune hemolytic anemia in a tertiary care hospital in North India.
        Ann Hematol. 2009; 88: 727-732
        • Issit P.
        Serological diagnosis and characterization of causative antibody.
        in: Hugh Chaplin J.R. Methods in Hematology- Immune Hemolytic Anemia. Churchill Livingston, USA1985
        • Sokol R.J.
        • Hewitt S.
        • Booker D.J.
        • et al.
        Red cell autoantibodies, multiple immunoglobulin classes, and autoimmune hemolysis.
        Transfusion. 1990; 30: 714-717
        • Fabijanska- Mitek J.
        • Namirska- Krzton H.
        • Seyfried H.
        The value of gel test and ELAT in autoimmune hemolytic anemia.
        Clin Lab Hematol. 1995; 17: 311-316
        • Zhang Y.
        • Chu Y.
        • Shao Z.
        The clinical implications of IgG subclass in 84 patients with autoimmune hemolytic anemia.
        Zhonghua Xue Ye Xue Za Zhi. 1999; 20: 524-526
        • Sokol R.J.
        • Booker D.J.
        • Stamps R.
        The pathology of autoimmune hemolytic anemia.
        J Clin Pathol. 1992; 45: 1047-1052
        • Das S.S.
        • Chakrapani A.
        • Bhattacharya S.
        • Biswas R.N.
        • Safi M.
        Immunohematological and clinical characterization of complement and non-complement associated warm autoimmune haemolytic anemia and risk factors predicting their occurrences.
        Indian J Hematol Blood Transfus. 2021; 37: 623-631
        • Das S.S.
        • Chaudhary R.K.
        Application of Gel Technology in the Serologic Characterization of Autoantibody in DAT-positive Autoimmune Diseases.
        Immunohematology. 2007; 23: 59-62
        • Lai M.
        • Leone G.
        • Landolfi R.
        Autoimmune hemolytic anemia with gel-based immunohematology tests.
        Am J Clin Pathol. 2013; 139: 457-463
        • Young P.P.
        • Uzieblo A.
        • Trulock E.
        • et al.
        Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?.
        Transfusion. 2004; 44: 67-72
        • Das S.S.
        • Chaudhary R.
        Utility of adsorption techniques in serological evaluation of AIHA in a hospital based transfusion service.
        Blood Transfus. 2009; 7: 300-304
        • Zhu J.Y.
        • Lan J.C.
        • Hu L.Y.
        • et al.
        Study on blood ABO typing in patients with autoimmune hemolytic anemia.
        Zhongguo shi Yan Xue Ye Xue Za Zhi. 2004; 12: 525-527
        • Petz L.D.
        A physician’s guide to transfusion in autoimmune hemolytic anemia.
        Br J Hematol. 2004; 124: 712-716
        • Das S.S.
        • Chaudhary R.
        Transfusion support in autoimmune hemolytic anemia.
        Indian J Hematol Blood Transfus. 2006; 1: 9-13